Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma.

"Declarations Ethics approval and consent to participateThe study was approved by the Institute Research Ethics Committee at the Sixth Affiliated Hospital of Sun Yat-sen University. Written informed consent was obtained from each patient. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This study was supported by National Natural Science Foundation of China (grant number 81902397), Major Talent Training Project of the Third Affiliated Hospital of Sun Yat-sen University (granted to Yi-Fan Lian), General Planned Project of Guangzhou Science and Technology (grant number 202201010950 and 202102080283), Fundamental Research Funds for the Central Universities (grant number 22qntd3401), Key Project of Rural Science and Technology Commissioner of Guangdong Province (grant number KPT20190263), Research Fund of Wu Jieping Medical Foundation (grant number 320.6750.2020-01-32) and Bethune-Tuoyi Young and Middle-aged Doctors' Research Ability Development Project (grant number BQE-TY-SSP(C-3)-S-03)."